Ramzi G Salloum1, Kayla R Getz2, Andy S L Tan3, Lisa Carter-Harris4, Kelly C Young-Wolff5, Thomas J George6, Elizabeth A Shenkman2. 1. Department of Health Outcomes and Policy, and Institute for Child Health Policy, University of Florida College of Medicine, Gainesville, Florida. Electronic address: rsalloum@ufl.edu. 2. Department of Health Outcomes and Policy, and Institute for Child Health Policy, University of Florida College of Medicine, Gainesville, Florida. 3. Department of Social and Behavioral Health, Harvard T.H. Chan School of Public Health, and Dana-Farber Cancer Institute, Boston, Massachusetts. 4. Indiana University School of Nursing, Indianapolis, Indiana. 5. Kaiser Permanente Northern California Division of Research, Oakland, California. 6. Department of Health Outcomes and Policy, and Institute for Child Health Policy, University of Florida College of Medicine, Gainesville, Florida; Department of Medicine, Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida.
Abstract
INTRODUCTION: The population-level patterns of electronic cigarette (e-cigarette) use among cancer survivors in the U.S. are unknown. The objective of this study was to examine the prevalence and correlates of e-cigarette use among cancer survivors in a nationally representative sample. METHODS: A cross-sectional analysis was conducted of the 2014 National Health Interview Survey of the U.S. non-institutionalized civilian population. The main study outcomes were the prevalence and correlates of ever and current e-cigarette use among adults with self-reported history of cancer, excluding non-melanoma skin cancer (N=2,695). Multivariable logistic regression analyses examined whether e-cigarette use differed by cigarette smoking status and demographic subgroups. The analyses were performed in 2015. RESULTS: The prevalence of e-cigarette use among adult cancer survivors was lower than the general population: 2.8% of cancer survivors reported currently using e-cigarettes and an additional 6.3% had previously used e-cigarettes but were not currently using them. Use of e-cigarettes was most common among cancer survivors who currently smoked cigarettes: 34.3% of current smokers were ever e-cigarette users and 15.6% were current e-cigarette users, compared with former smokers (2.7% ever and 1.4% current e-cigarette users) and never smokers (small sample/estimates unavailable). CONCLUSIONS: E-cigarettes are not part of current evidence-based smoking-cessation strategies. However, the finding that cancer survivors who currently smoke cigarettes are more likely to use e-cigarettes highlights the importance of addressing e-cigarette use in patient-provider communications around tobacco cessation.
INTRODUCTION: The population-level patterns of electronic cigarette (e-cigarette) use among cancer survivors in the U.S. are unknown. The objective of this study was to examine the prevalence and correlates of e-cigarette use among cancer survivors in a nationally representative sample. METHODS: A cross-sectional analysis was conducted of the 2014 National Health Interview Survey of the U.S. non-institutionalized civilian population. The main study outcomes were the prevalence and correlates of ever and current e-cigarette use among adults with self-reported history of cancer, excluding non-melanoma skin cancer (N=2,695). Multivariable logistic regression analyses examined whether e-cigarette use differed by cigarette smoking status and demographic subgroups. The analyses were performed in 2015. RESULTS: The prevalence of e-cigarette use among adult cancer survivors was lower than the general population: 2.8% of cancer survivors reported currently using e-cigarettes and an additional 6.3% had previously used e-cigarettes but were not currently using them. Use of e-cigarettes was most common among cancer survivors who currently smoked cigarettes: 34.3% of current smokers were ever e-cigarette users and 15.6% were current e-cigarette users, compared with former smokers (2.7% ever and 1.4% current e-cigarette users) and never smokers (small sample/estimates unavailable). CONCLUSIONS: E-cigarettes are not part of current evidence-based smoking-cessation strategies. However, the finding that cancer survivors who currently smoke cigarettes are more likely to use e-cigarettes highlights the importance of addressing e-cigarette use in patient-provider communications around tobacco cessation.
Authors: I-Chan Huang; James L Klosky; Chelsea M Young; Sharon E Murphy; Kevin K Krull; DeoKumar Srivastava; Melissa M Hudson; Leslie L Robison Journal: Pediatr Blood Cancer Date: 2018-06-01 Impact factor: 3.167
Authors: Godfred O Antwi; David K Lohrmann; Wasantha Jayawardene; Angela Chow; Cecilia S Obeng; Aaron M Sayegh Journal: J Cancer Surviv Date: 2019-04-06 Impact factor: 4.442
Authors: Yael R Symes; Kurt M Ribisl; Marcella H Boynton; J Lee Westmaas; Deborah K Mayer; Shelley D Golden Journal: J Cancer Surviv Date: 2019-01-24 Impact factor: 4.442
Authors: Allison M Glasser; Lauren Collins; Jennifer L Pearson; Haneen Abudayyeh; Raymond S Niaura; David B Abrams; Andrea C Villanti Journal: Am J Prev Med Date: 2016-11-30 Impact factor: 5.043
Authors: Ramzi G Salloum; Jinhai Huo; Ji-Hyun Lee; Juhan Lee; Jesse Dallery; Thomas George; Graham Warren Journal: PLoS One Date: 2019-12-09 Impact factor: 3.240
Authors: Sara Kalkhoran; Gina R Kruse; Nancy A Rigotti; Julia Rabin; Jamie S Ostroff; Elyse R Park Journal: Cancer Med Date: 2018-06-14 Impact factor: 4.452